XML 36 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair value measurements (Tables)
6 Months Ended
Jun. 30, 2018
Fair Value Disclosures [Abstract]  
Financial Instruments Measured At Fair Value On A Recurring Basis
Financial instruments measured at fair value on a recurring basis, by valuation hierarchy
June 30, 2018
Level 1

 
Level 2

 
Level 3

 
Total

(in millions of U.S. dollars)
 
 
 
Assets:
 
 
 
 
 
 
 
Fixed maturities available for sale
 
 
 
 
 
 
 
U.S. Treasury and agency
$
2,939

 
$
825

 
$

 
$
3,764

Foreign

 
21,759

 
252

 
22,011

Corporate securities

 
23,304

 
1,181

 
24,485

Mortgage-backed securities

 
15,401

 
82

 
15,483

States, municipalities, and political subdivisions

 
12,220

 

 
12,220

 
2,939

 
73,509

 
1,515

 
77,963

Equity securities
874

 

 
59

 
933

Short-term investments
1,750

 
1,409

 
12

 
3,171

Other investments (1)
424

 
326

 
264

 
1,014

Securities lending collateral

 
2,355

 

 
2,355

Investment derivative instruments
39

 

 

 
39

Other derivative instruments
50

 

 

 
50

Separate account assets
2,862

 
116

 

 
2,978

Total assets measured at fair value (1)
$
8,938

 
$
77,715

 
$
1,850

 
$
88,503

Liabilities:
 
 
 
 
 
 
 
Investment derivative instruments
$
42

 
$

 
$

 
$
42

Other derivative instruments

 

 
2

 
2

GLB (2)

 

 
125

 
125

Total liabilities measured at fair value
$
42

 
$

 
$
127

 
$
169

(1) 
Excluded from the table above are partially-owned investments, investment funds, and limited partnerships of $4,224 million and other investments of $21 million at June 30, 2018 measured using NAV as a practical expedient.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets.
 
December 31, 2017
Level 1

 
Level 2

 
Level 3

 
Total

(in millions of U.S. dollars)
 
 
 
Assets:
 
 
 
 
 
 
 
Fixed maturities available for sale
 
 
 
 
 
 
 
U.S. Treasury and agency
$
3,129

 
$
569

 
$

 
$
3,698

Foreign

 
20,937

 
93

 
21,030

Corporate securities

 
22,959

 
1,037

 
23,996

Mortgage-backed securities

 
15,212

 
78

 
15,290

States, municipalities, and political subdivisions

 
14,925

 

 
14,925

 
3,129

 
74,602

 
1,208

 
78,939

Equity securities
893

 

 
44

 
937

Short-term investments
2,309

 
1,252

 

 
3,561

Other investments (1)
466

 
305

 
263

 
1,034

Securities lending collateral

 
1,737

 

 
1,737

Investment derivative instruments
18

 

 

 
18

Other derivative instruments
1

 

 

 
1

Separate account assets
2,635

 
99

 

 
2,734

Total assets measured at fair value (1)
$
9,451

 
$
77,995

 
$
1,515

 
$
88,961

Liabilities:
 
 
 
 
 
 
 
Investment derivative instruments
$
30

 
$

 
$

 
$
30

Other derivative instruments
21

 

 
2

 
23

GLB (2)

 

 
204

 
204

Total liabilities measured at fair value
$
51

 
$

 
$
206

 
$
257


(1) 
Excluded from the table above are partially-owned investments, investment funds, and limited partnerships of $3,623 million and other investments of $15 million at December 31, 2017 measured using NAV as a practical expedient.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets.
Fair Value And Maximum Future Funding Commitments Related To Investments
The following table presents, by investment category, the expected liquidation period, fair value, and maximum future funding commitments of alternative investments:
 
 
 
 
 
June 30

 
 
 
December 31

 
Expected
Liquidation
Period of Underlying Assets
 
 
 
2018

 
 
 
2017

(in millions of U.S. dollars)
Fair
Value

 
Maximum
Future Funding
Commitments

 
Fair
Value

 
Maximum
Future Funding
Commitments

Financial
5 to 9 Years
 
$
569

 
$
281

 
$
540

 
$
330

Real Assets
3 to 7 Years
 
673

 
192

 
651

 
114

Distressed
3 to 7 Years
 
279

 
131

 
289

 
141

Private Credit
3 to 7 Years
 
184

 
308

 
187

 
327

Traditional
3 to 15 Years
 
2,177

 
2,529

 
1,656

 
3,149

Vintage
1 to 2 Years
 
64

 

 
30

 

Investment funds
Not Applicable
 
278

 

 
270

 

 
 
 
$
4,224

 
$
3,441

 
$
3,623

 
$
4,061

Schedule Of Significant Unobservable Inputs Used In Level 3 Liability Valuations
The following table presents the significant unobservable inputs used in the Level 3 liability valuations. Excluded from the table below are inputs used to determine the fair value of Level 3 assets which are based on single broker quotes and contain no quantitative unobservable inputs developed by management.
(in millions of U.S. dollars, except for percentages)
Fair Value
 
 
Valuation
Technique
 
Significant
Unobservable Inputs
 
Ranges
June 30, 2018

 
December 31, 2017

 
 
 
GLB (1)
$
125

 
$
204

 
Actuarial model
 
Lapse rate
 
3% – 33%
 
 
 
 
 
 
 
Annuitization rate
 
0% – 100%
(1) 
Discussion of the most significant inputs used in the fair value measurement of GLB and the sensitivity of those assumptions is included within Note 3 a) Guaranteed living benefits.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following tables present a reconciliation of the beginning and ending balances of financial instruments measured at fair value using significant unobservable inputs (Level 3):
 
Assets
 
 
Liabilities
 
Three Months Ended
Available-for-Sale Debt Securities
Equity
securities

 
Short-term investments

 
Other
investments

 
Other
derivative
instruments

 
GLB (2)

June 30, 2018
Foreign

 
Corporate
securities (1)

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
176

 
$
1,073

 
$
83

 
$
64

 
$
12

 
$
270

 
$
2

 
$
167

Transfers into Level 3

 
6

 

 

 

 

 

 

Transfers out of Level 3

 

 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
(7
)
 
(9
)
 

 

 

 

 

 

Net Realized Gains/Losses

 
2

 

 
(3
)
 

 
1

 

 
(42
)
Purchases
95

 
217

 

 
3

 
1

 
16

 

 

Sales
(11
)
 
(45
)
 

 
(5
)
 

 

 

 

Settlements
(1
)
 
(63
)
 
(1
)
 

 
(1
)
 
(23
)
 

 

Balance – end of period
$
252

 
$
1,181

 
$
82

 
$
59

 
$
12

 
$
264

 
$
2

 
$
125

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$
(3
)
 
$

 
$
1

 
$

 
$
(42
)
(1) 
Purchases in Level 3 primarily consist of privately-placed fixed income securities.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $497 million at June 30, 2018, and $529 million at March 31, 2018, which includes a fair value derivative adjustment of $125 million and $167 million, respectively.

  
Assets
 
 
 
 
Liabilities

Three Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Short-term investments

 
Other
investments

 
Other derivative instruments

 
GLB (1)

June 30, 2017
Foreign

 
Corporate
securities

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
80

 
$
737

 
$
45

 
$
41

 
$
21

 
$
233

 
$
11

 
$
466

Transfers into Level 3

 
28

 

 

 

 

 

 
9

Transfers out of Level 3

 
(13
)
 

 

 

 

 
(9
)
 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
3

 

 

 
1

 

 
(1
)
 

 

Net Realized Gains/Losses
2

 

 

 

 

 

 

 
(118
)
Purchases
19

 
65

 

 
6

 
7

 
16

 

 

Sales
(19
)
 
(28
)
 

 
(9
)
 

 

 

 

Settlements

 
(42
)
 

 

 
(21
)
 
(5
)
 

 

Balance – end of period
$
85

 
$
747

 
$
45

 
$
39

 
$
7

 
$
243

 
$
2

 
$
357

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$
(118
)
(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $684 million at June 30, 2017, and $774 million at March 31, 2017, which includes a fair value derivative adjustment of $357 million and $466 million, respectively.
 
Assets
 
 
Liabilities
 
Six Months Ended
Available-for-Sale Debt Securities
Equity
securities

 
Short-term investments

 
Other
investments

 
Other
derivative
instruments

 
GLB(2)

June 30, 2018
Foreign

 
Corporate
securities (1)

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
93

 
$
1,037

 
$
78

 
$
44

 
$

 
$
263

 
$
2

 
$
204

Transfers into Level 3
7

 
6

 
1

 

 
5

 

 

 

Transfers out of Level 3

 
(10
)
 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
2

 
(12
)
 

 
1

 

 
2

 

 

Net Realized Gains/Losses

 
2

 

 
(1
)
 

 
1

 

 
(79
)
Purchases
182

 
356

 
4

 
20

 
9

 
30

 

 

Sales
(30
)
 
(96
)
 

 
(5
)
 

 

 

 

Settlements
(2
)
 
(102
)
 
(1
)
 

 
(2
)
 
(32
)
 

 

Balance – end of period
$
252

 
$
1,181

 
$
82

 
$
59

 
$
12

 
$
264

 
$
2

 
$
125

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$
(1
)
 
$

 
$
1

 
$

 
$
(79
)
(1) 
Purchases in Level 3 primarily consist of privately-placed fixed income securities.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $497 million at June 30, 2018, and $550 million at December 31, 2017, which includes a fair value derivative adjustment of $125 million and $204 million, respectively.
  
Assets
 
 
 
 
Liabilities

Six Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Short-term investments

 
Other
investments

 
Other derivative instruments

 
GLB(1)

June 30, 2017
Foreign

 
Corporate
securities

 
MBS

 
 
 
 
(in millions of U.S. dollars)
 
 
 
 
 
 
Balance – beginning of period
$
74

 
$
681

 
$
45

 
$
41

 
$
25

 
$
225

 
$
13

 
$
559

Transfers into Level 3

 
57

 

 

 

 

 

 
9

Transfers out of Level 3

 
(67
)
 

 

 

 

 
(9
)
 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
2

 
(8
)
 

 
1

 

 
3

 

 

Net Realized Gains/Losses
1

 
(1
)
 

 

 

 

 
(2
)
 
(211
)
Purchases
33

 
221

 
1

 
6

 
14

 
24

 

 

Sales
(22
)
 
(55
)
 
(1
)
 
(9
)
 

 

 

 

Settlements
(3
)
 
(81
)
 

 

 
(32
)
 
(9
)
 

 

Balance – end of period
$
85

 
$
747

 
$
45

 
$
39

 
$
7

 
$
243

 
$
2

 
$
357

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$

 
$

 
$

 
$
(2
)
 
$
(211
)
(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $684 million at June 30, 2017, and $853 million at December 31, 2016, which includes a fair value derivative adjustment of $357 million and $559 million, respectively.

b
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following tables present a reconciliation of the beginning and ending balances of financial instruments measured at fair value using significant unobservable inputs (Level 3):
 
Assets
 
 
Liabilities
 
Three Months Ended
Available-for-Sale Debt Securities
Equity
securities

 
Short-term investments

 
Other
investments

 
Other
derivative
instruments

 
GLB (2)

June 30, 2018
Foreign

 
Corporate
securities (1)

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
176

 
$
1,073

 
$
83

 
$
64

 
$
12

 
$
270

 
$
2

 
$
167

Transfers into Level 3

 
6

 

 

 

 

 

 

Transfers out of Level 3

 

 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
(7
)
 
(9
)
 

 

 

 

 

 

Net Realized Gains/Losses

 
2

 

 
(3
)
 

 
1

 

 
(42
)
Purchases
95

 
217

 

 
3

 
1

 
16

 

 

Sales
(11
)
 
(45
)
 

 
(5
)
 

 

 

 

Settlements
(1
)
 
(63
)
 
(1
)
 

 
(1
)
 
(23
)
 

 

Balance – end of period
$
252

 
$
1,181

 
$
82

 
$
59

 
$
12

 
$
264

 
$
2

 
$
125

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$
(3
)
 
$

 
$
1

 
$

 
$
(42
)
(1) 
Purchases in Level 3 primarily consist of privately-placed fixed income securities.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $497 million at June 30, 2018, and $529 million at March 31, 2018, which includes a fair value derivative adjustment of $125 million and $167 million, respectively.

  
Assets
 
 
 
 
Liabilities

Three Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Short-term investments

 
Other
investments

 
Other derivative instruments

 
GLB (1)

June 30, 2017
Foreign

 
Corporate
securities

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
80

 
$
737

 
$
45

 
$
41

 
$
21

 
$
233

 
$
11

 
$
466

Transfers into Level 3

 
28

 

 

 

 

 

 
9

Transfers out of Level 3

 
(13
)
 

 

 

 

 
(9
)
 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
3

 

 

 
1

 

 
(1
)
 

 

Net Realized Gains/Losses
2

 

 

 

 

 

 

 
(118
)
Purchases
19

 
65

 

 
6

 
7

 
16

 

 

Sales
(19
)
 
(28
)
 

 
(9
)
 

 

 

 

Settlements

 
(42
)
 

 

 
(21
)
 
(5
)
 

 

Balance – end of period
$
85

 
$
747

 
$
45

 
$
39

 
$
7

 
$
243

 
$
2

 
$
357

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$
(118
)
(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $684 million at June 30, 2017, and $774 million at March 31, 2017, which includes a fair value derivative adjustment of $357 million and $466 million, respectively.
 
Assets
 
 
Liabilities
 
Six Months Ended
Available-for-Sale Debt Securities
Equity
securities

 
Short-term investments

 
Other
investments

 
Other
derivative
instruments

 
GLB(2)

June 30, 2018
Foreign

 
Corporate
securities (1)

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
93

 
$
1,037

 
$
78

 
$
44

 
$

 
$
263

 
$
2

 
$
204

Transfers into Level 3
7

 
6

 
1

 

 
5

 

 

 

Transfers out of Level 3

 
(10
)
 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
2

 
(12
)
 

 
1

 

 
2

 

 

Net Realized Gains/Losses

 
2

 

 
(1
)
 

 
1

 

 
(79
)
Purchases
182

 
356

 
4

 
20

 
9

 
30

 

 

Sales
(30
)
 
(96
)
 

 
(5
)
 

 

 

 

Settlements
(2
)
 
(102
)
 
(1
)
 

 
(2
)
 
(32
)
 

 

Balance – end of period
$
252

 
$
1,181

 
$
82

 
$
59

 
$
12

 
$
264

 
$
2

 
$
125

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$
(1
)
 
$

 
$
1

 
$

 
$
(79
)
(1) 
Purchases in Level 3 primarily consist of privately-placed fixed income securities.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $497 million at June 30, 2018, and $550 million at December 31, 2017, which includes a fair value derivative adjustment of $125 million and $204 million, respectively.
  
Assets
 
 
 
 
Liabilities

Six Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Short-term investments

 
Other
investments

 
Other derivative instruments

 
GLB(1)

June 30, 2017
Foreign

 
Corporate
securities

 
MBS

 
 
 
 
(in millions of U.S. dollars)
 
 
 
 
 
 
Balance – beginning of period
$
74

 
$
681

 
$
45

 
$
41

 
$
25

 
$
225

 
$
13

 
$
559

Transfers into Level 3

 
57

 

 

 

 

 

 
9

Transfers out of Level 3

 
(67
)
 

 

 

 

 
(9
)
 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
2

 
(8
)
 

 
1

 

 
3

 

 

Net Realized Gains/Losses
1

 
(1
)
 

 

 

 

 
(2
)
 
(211
)
Purchases
33

 
221

 
1

 
6

 
14

 
24

 

 

Sales
(22
)
 
(55
)
 
(1
)
 
(9
)
 

 

 

 

Settlements
(3
)
 
(81
)
 

 

 
(32
)
 
(9
)
 

 

Balance – end of period
$
85

 
$
747

 
$
45

 
$
39

 
$
7

 
$
243

 
$
2

 
$
357

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$

 
$

 
$

 
$
(2
)
 
$
(211
)
(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $684 million at June 30, 2017, and $853 million at December 31, 2016, which includes a fair value derivative adjustment of $357 million and $559 million, respectively.

b
Carrying Values And Fair Values Of Financial Instruments Not Measured At Fair Value
he following tables present fair value, by valuation hierarchy, and carrying value of the financial instruments not measured at fair value:
June 30, 2018
Fair Value
 
 
Carrying Value

(in millions of U.S. dollars)
Level 1

 
Level 2

 
Level 3

 
Total

 
Assets:
 
 
 
 
 
 
 
 
 
Fixed maturities held to maturity
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency
$
1,079

 
$
54

 
$

 
$
1,133

 
$
1,143

Foreign

 
1,675

 

 
1,675

 
1,678

Corporate securities

 
2,633

 
32

 
2,665

 
2,736

Mortgage-backed securities

 
2,585

 

 
2,585

 
2,640

States, municipalities, and political subdivisions

 
5,607

 

 
5,607

 
5,663

Total assets
$
1,079

 
$
12,554

 
$
32

 
$
13,665

 
$
13,860

Liabilities:
 
 
 
 
 
 
 
 
 
Repurchase agreements
$

 
$
1,413

 
$

 
$
1,413

 
$
1,413

Short-term debt

 
615

 

 
615

 
600

Long-term debt

 
12,296

 

 
12,296

 
12,184

Trust preferred securities

 
433

 

 
433

 
308

Total liabilities
$

 
$
14,757

 
$

 
$
14,757

 
$
14,505


December 31, 2017
Fair Value
 
 
Carrying Value

(in millions of U.S. dollars)
Level 1

 
Level 2

 
Level 3

 
Total

 
Assets:
 
 
 
 
 
 
 
 
 
Fixed maturities held to maturity
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency
$
857

 
$
58

 
$

 
$
915

 
$
908

Foreign

 
1,757

 

 
1,757

 
1,738

Corporate securities

 
3,184

 
35

 
3,219

 
3,159

Mortgage-backed securities

 
2,742

 

 
2,742

 
2,724

States, municipalities, and political subdivisions

 
5,841

 

 
5,841

 
5,806

Total assets
$
857


$
13,582


$
35


$
14,474


$
14,335

Liabilities:
 
 
 
 
 
 
 
 
 
Repurchase agreements
$

 
$
1,408

 
$

 
$
1,408

 
$
1,408

Short-term debt

 
1,013

 

 
1,013

 
1,013

Long-term debt

 
12,332

 

 
12,332

 
11,556

Trust preferred securities

 
468

 

 
468

 
308

Total liabilities
$

 
$
15,221

 
$

 
$
15,221

 
$
14,285